You are here

Not Available

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N43CO201000096
Agency Tracking Number: N43CO201000096
Amount: $297,532.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NCI
Solicitation Number: PHS2010-1
Timeline
Solicitation Year: 2010
Award Year: 2010
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
100 RIVER PLACE, SUITE 6800
DETROIT, MI 48207-
United States
DUNS: 044306905
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 Nalini Motwani
 (313) 446-2625
 nmotwani@apolife.com
Business Contact
Phone: (313) 446-2625
Email: nmotwani@apolife.com
Research Institution
N/A
Abstract

ApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains producing homogeneous human N-linked glycosylated proteins, ApoLife will develop commercial scale process for cost effective manufacturing of Campth, anticancer antibody, as a biogeneric antibody candidate. ApoLife has expressed Campath genes in yeast system.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government